Levuglandin E₂−Protein Adducts in Human Plasma and Vasculature

Nugteren D. H., 1980, Chemical and enzymatic conversion of the prostaglandin endoperoxide PGH2. Adv. Prostaglandin Thromboxane Res. 6, 129−137

Salomon R. G., 1984, J. Am. Chem. Soc., 106

Salomon R. G., 1987, Prostaglandin endoperoxides 21. Covalent binding of levuglandin E2 with proteins. Prostaglandins 34, 643−656

Jackson A. H., 1980, Comprehensive Organic Chemistry, 320

Iyer R., 1994, J. Org. Chem., 59, 10.1021/jo00099a039

DiFranco E., 1995, Chem. Res. Toxicol., 8, 67, 10.1021/tx00043a008

Miller D. B., 1990, J. Org. Chem., 55

Kobierski M. E., 1994, J. Org. Chem., 59, 10.1021/jo00099a040

Palinski W., 1990, Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10, 325−335

Hatch F. T., 1968, Adv. Lipid. Res., 6, 63

Harlow E., 1988, Cold Spring Harbor Laboratory

Smith M. A., 1994, Proc. Natl. Acad. Sci. U.S.A. 91

Iyer R. S., 1989, Levuglandin E2 crosslinks proteins. Prostaglandins 37, 471−479

Jirousek M. R., 1990, Electrophilic levuglandin E2-protein adducts bind glycine:  a model for protein crosslinking. Prostaglandins 40, 187−203

Murthi K. K., 1993, Formation of DNA-protein cross-links in mammalian cells by Levuglandin E2. Biochemistry 32, 4090−4097

Schmidley J. W., 1992, Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2. Prostaglandins Leukotrienes Essent. Fatty Acids 47, 105−110

Van Der Vusse G. J., 1982, Uptake and tissue content of fatty acids in dog myocardium under normoxic and ischemic conditions. Circ. Res. 50, 538−546

Chien, K. R., Sen, A., Han, A., Buja, L. M., and Willerson, J. T. (1984) Accumulation of unesterified arachidonic acid in ischemic canine myocardium. Relationship to a phosphatidylcholine deacylation-reacylation cycle and the depletion of membrane phospholipids.Circ. Res.54, 313−322.

Siesjo B. K., 1983, Cerebrovascular Diseases

Bazan N. G., Jr., 1970, Biochim. Biophys. Acta, 218, 10

Ginsberg M. D., 1983, Cerebrovascular Diseases

Fishman R. A., 1981, Trans. Am. Neurol. Assoc., 106, 61

Coker S. J., 1981, Thromboxane and prostacyclin release from ischemic myocardium in relation to arrhythmias. Nature 291, 323−324

Robertson R. M., 1981, N. Engl. J. Med., 304, 10.1056/NEJM198104233041703

Berger H. J., 1977, Am. J. Cardiol., 39, 10.1016/S0002-9149(77)80154-9

Hsueh W., 1978, Sites of lipase activation and prostaglandin synthesis in isolated, perfused rabbit hearts and hydronephrotic kidneys. Prostaglandins 16, 661−681

Hirsh P. D., 1981, N. Engl. J. Med., 304, 10.1056/NEJM198103193041201

Gaudet R. J., 1980, J. Neurochem., 35, 10.1111/j.1471-4159.1980.tb03704.x

Gaudet R. J., 1979, Transient cerebral ischemia and brain prostaglandins. Biochem. Biophys. Res. Commun. 86, 893−901

Flower R. J., 1973, Quantitative determination of prostaglandins and malondialdehyde formed by the arachidonate oxygenase (prostaglandin synthetase) system of bovine seminal vesicle. Prostaglandins 4, 325−341, 10.1016/0090-6980(73)90020-8

Morrow J. D., 1990, Anal. Biochem., 184, 10, 10.1016/0003-2697(90)90002-Q

Porter N. A., 1975, J. Org. Chem., 40, 10.1021/jo00912a037

Corey E. J., 1984, Tetrahedron Lett., 25

Jürgens G., 1986, Biochim. Biophys. Acta, 875

Esterbauer H., 1987, J. Lipid Res., 28, 10.1016/S0022-2275(20)38678-8

Esterbauer H., 1992, The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radical Biol. Med. 13, 341−390

Steinbrecher U. P., 1987, J. Biol. Chem., 262, 10.1016/S0021-9258(18)61395-X

Fogelman A. M., 1980, Proc. Natl. Acad. Sci. U.S.A. 77

Palinski W., 1989, Proc. Natl. Acad. Sci. U.S.A. 86

Haberland M. E., 1988, Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241, 215−218

Holvoet P., 1995, J. Clin. Invest., 95, 10.1172/JCI117963

Morrow J. D., 1990, Proc. Natl. Acad. Sci. U.S.A. 87

Morrow J. D., 1994, J. Biol. Chem., 269

Salomon R. G., 1985, Prostaglandin endoperoxide reaction mechanisms and the discovery of levuglandins. Acc. Chem. Res. 18, 294−301

Lynch S. M., 1994, J. Clin. Invest., 93, 10.1172/JCI117107

Smith M. A., 1994, Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Ann. N. Y. Acad. Sci. 738, 447−454

Smith M. A., 1996, Free Radicals in Brain Physiology and Disorders

Abbreviations AA, arachidonic acid